1. Search Result
Search Result
Results for "

FGF23

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

1

Inhibitory Antibodies

1

Natural
Products

6

Recombinant Proteins

4

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-N1428C
    Ferric citrate
    5 Publications Verification

    Iron(III) citrate; Zerenex

    Reactive Oxygen Species (ROS) Antibiotic Metabolic Disease
    Ferric citrate (Iron(III) citrate), an orally active iron supplement, is an efficacious phosphate binder. Ferric citratee can be used for iron deficiency anemia and chronic kidney disease (CKD) research .
    Ferric citrate
  • HY-150687

    ERK Metabolic Disease
    ZINC12409120 is a high selective ERK inhibitor. ZINC12409120 acts on disrupting FGF23:α-Klotho interaction to inhibit ERK activity with an IC50 of 5.0 μM .
    ZINC12409120
  • HY-125961

    FGFR Glycosyltransferase Cancer
    T3Inh-1 is a potent and selective inhibitor of ppGalNAc-T3 (IC50=7 μM). T3Inh-1 reduces FGF23 hormone levels in both tissue cells and mice, without causing any toxic side effects. T3Inh-1 also prevents breast cancer cells. The enzyme ppGalNAc-T3 is implicated in at least two medically important pathways: cancer metastasis and stabilization of FGF23 (regulates phosphate levels in the bloodstream) .
    T3Inh-1
  • HY-174698

    mRNA Cancer
    Human FGF23 mRNA encodes the human fibroblast growth factor 23 (FGF23) protein, a member of the fibroblast growth factor (FGF) family. FGF23 regulates phosphate homeostasis and transport in the kidney.
    Human FGF23 mRNA
  • HY-RS04900

    Small Interfering RNA (siRNA) Others

    FGF23 Human Pre-designed siRNA Set A contains three designed siRNAs for FGF23 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    FGF23 Human Pre-designed siRNA Set A
    FGF23 Human Pre-designed siRNA Set A
  • HY-RS23171

    Small Interfering RNA (siRNA) Others

    Fgf23 Rat Pre-designed siRNA Set A contains three designed siRNAs for Fgf23 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Fgf23 Rat Pre-designed siRNA Set A
    Fgf23 Rat Pre-designed siRNA Set A
  • HY-W012856

    3-Methylethylbenzene

    Reactive Oxygen Species (ROS) FGFR TGF-β Receptor MMP Metabolic Disease
    3-Ethyltoluene (3-Methylethylbenzene) is an isomer of Ethyltoluenes. 3-Ethyltoluene inhibits cell survival and proliferation and increases ROS production. 3-Ethyltoluene upregulates cellular inflammatory gene expression. 3-Ethyltoluene induces cell fibrosis with increased level of AST, FGF-23, Cyt-7 p21, TGFβ, TIMP2, and MMP2. 3-Ethyltoluene can be used for liver diseases such as NAFLD research .
    3-Ethyltoluene
  • HY-RS16734

    Small Interfering RNA (siRNA) Others

    Fgf23 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Fgf23 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Fgf23 Mouse Pre-designed siRNA Set A
    Fgf23 Mouse Pre-designed siRNA Set A
  • HY-183371

    FGFR Metabolic Disease
    ZINC13407541 is a fibroblast growth factor 23 (FGF23) antagonist with an IC50 of 0.45 μM. ZINC13407541 preferentially binds to the FGF23:FGFR interface to disrupt their protein-protein interactions. ZINC13407541 can be used for the research of hypophosphatemia .
    ZINC13407541
  • HY-186173

    ERK FGFR Metabolic Disease
    MD-3-A45 is an inhibitor of fibroblast growth factor 23 (FGF-23). MD-3-A45 blocks the activation of the FGFRs/α-klotho signaling pathway by FGF-23 and inhibits FGF-23-induced ERK activation. MD-3-A45 can be used in the research of chronic kidney disease, hereditary hypophosphatemic rickets and acquired hypophosphatemic rickets .
    MD-3-A45
  • HY-159978

    Sodium Phosphate Cotransporter Metabolic Disease Inflammation/Immunology
    EOS789 is an orally active sodium-dependent phosphate transporter inhibitor, with IC50 values of 6.8, 1.5, and 1.7 μM against human NaPi-IIb, PiT-1, PiT-2, respectively; and IC50 values of 3.9, 1.9, and 1.7 μM against rat NaPi-IIb, PiT-1, PiT-2, respectively. EOS789 inhibits intestinal phosphate absorption, increases fecal phosphate excretion, reduces urinary phosphate excretion, and decreases the levels of serum phosphate, FGF23, and adult parathyroid hormone. EOS789 ameliorates ectopic thoracic aortic calcification, renal injury and hyperphosphatemia, and inhibits the expression of fibrosis markers. EOS789 can be used for the research of hyperphosphatemia and chronic kidney disease-mineral and bone disorder (CKD-MBD) .
    EOS789

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: